• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology.

作者信息

Schnipper Lowell E, Smith Thomas J, Raghavan Derek, Blayney Douglas W, Ganz Patricia A, Mulvey Therese Marie, Wollins Dana S

机构信息

Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

出版信息

J Clin Oncol. 2012 May 10;30(14):1715-24. doi: 10.1200/JCO.2012.42.8375. Epub 2012 Apr 3.

DOI:10.1200/JCO.2012.42.8375
PMID:22493340
Abstract
摘要

相似文献

1
American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology.美国临床肿瘤学会确定了改善医疗服务并降低成本的五个关键机遇：肿瘤学领域的五大机遇。
J Clin Oncol. 2012 May 10;30(14):1715-24. doi: 10.1200/JCO.2012.42.8375. Epub 2012 Apr 3.
2
American Society of Clinical Oncology guidance statement: the cost of cancer care.美国临床肿瘤学会指导声明：癌症护理的成本
J Clin Oncol. 2009 Aug 10;27(23):3868-74. doi: 10.1200/JCO.2009.23.1183. Epub 2009 Jul 6.
3
Revised RECIST guideline version 1.1: What oncologists want to know and what radiologists need to know.修订版 RECIST 指南 1.1：肿瘤学家想知道的和放射科医生需要知道的。
AJR Am J Roentgenol. 2010 Aug;195(2):281-9. doi: 10.2214/AJR.09.4110.
4
The American Society of Clinical Oncology guideline program.美国临床肿瘤学会指南项目
Pharm Pract Manag Q. 1996 Apr;16(1):31-8.
5
Development and future of the American Society of Clinical Oncology's Quality Oncology Practice Initiative.美国临床肿瘤学会优质肿瘤医疗实践倡议的发展与未来
J Clin Oncol. 2014 Dec 10;32(35):3907-13. doi: 10.1200/JCO.2014.56.8899. Epub 2014 Sep 15.
6
The NCCN 23rd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care.美国国立综合癌症网络（NCCN）第23届年会：提高癌症护理的质量、有效性和效率。
J Natl Compr Canc Netw. 2018 May;16(5S):575-576.
7
Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.临床肿瘤进展 2011：美国临床肿瘤学会癌症进展年度报告。
J Clin Oncol. 2012 Jan 1;30(1):88-109. doi: 10.1200/JCO.2011.40.1919. Epub 2011 Dec 5.
8
American Society of Clinical Oncology 2013 top five list in oncology.美国临床肿瘤学会2013年肿瘤学五大榜单。
J Clin Oncol. 2013 Dec 1;31(34):4362-70. doi: 10.1200/JCO.2013.53.3943. Epub 2013 Oct 29.
9
American Society of Clinical Oncology clinical practice guidelines: opportunities and challenges.美国临床肿瘤学会临床实践指南：机遇与挑战
J Clin Oncol. 2008 Aug 20;26(24):4022-6. doi: 10.1200/JCO.2008.17.7139.
10
Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.《2009年临床癌症进展：癌症治疗、预防及筛查方面的重大研究进展——美国临床肿瘤学会报告》
J Clin Oncol. 2009 Dec 10;27(35):6052-69. doi: 10.1200/JCO.2009.26.6171. Epub 2009 Nov 9.

引用本文的文献

1
Systemic anticancer therapy during end of life in head and neck squamous cell carcinoma patients. A retrospective single center study.头颈部鳞状细胞癌患者临终时的全身抗癌治疗。一项回顾性单中心研究。
J Cancer Res Clin Oncol. 2025 Aug 29;151(8):240. doi: 10.1007/s00432-025-06297-5.
2
A pragmatic, single-arm clinical trial of a dose modification algorithm for preventing cytopenia-related delays during FOLFOX chemotherapy.一项关于预防FOLFOX化疗期间血细胞减少相关延迟的剂量调整算法的务实单臂临床试验。
Support Care Cancer. 2025 Aug 8;33(9):769. doi: 10.1007/s00520-025-09784-0.
3
Exploring behavioural motivations of treatment refusal in cancer: a Q-methodological approach.
探索癌症患者拒绝治疗的行为动机：一种Q方法学途径。
Support Care Cancer. 2025 Jul 8;33(8):667. doi: 10.1007/s00520-025-09666-5.
4
Association Between Baseline Neutrophil Count and Febrile Neutropenia Following Docetaxel and Ramucirumab With Prophylactic Pegfilgrastim.多西他赛和雷莫西尤单抗联合预防性聚乙二醇化重组人粒细胞刺激因子治疗后基线中性粒细胞计数与发热性中性粒细胞减少症之间的关联
Thorac Cancer. 2025 Jun;16(11):e70099. doi: 10.1111/1759-7714.70099.
5
Systemic anticancer therapy at the end of life: real-world insights from a tertiary oncology center in Israel.临终时的全身抗癌治疗：来自以色列一家三级肿瘤中心的真实世界见解。
Oncologist. 2025 May 8;30(5). doi: 10.1093/oncolo/oyaf066.
6
Impact of the implementation of an embedded palliative care model in the continuum of care for patients with metastatic breast cancer.在转移性乳腺癌患者连续护理中实施嵌入式姑息治疗模式的影响。
Support Care Cancer. 2025 May 5;33(6):449. doi: 10.1007/s00520-025-09502-w.
7
Early Specialist Palliative Care in Patients with Metastatic Cancer: A Population-Based Cohort Study.转移性癌症患者的早期专科姑息治疗：一项基于人群的队列研究。
J Pain Symptom Manage. 2025 Aug;70(2):140-148.e2. doi: 10.1016/j.jpainsymman.2025.04.005. Epub 2025 Apr 17.
8
Trends and Predictors of Palliative Therapy Use in Young Adults with Advanced Gastrointestinal Cancer: A National Cancer Database Study.晚期胃肠癌青年患者姑息治疗使用的趋势与预测因素：一项国家癌症数据库研究
Ann Surg Oncol. 2025 Jun;32(6):4261-4271. doi: 10.1245/s10434-025-17074-6. Epub 2025 Mar 3.
9
Contemporary Patterns of End-of-Life Care Among Medicare Beneficiaries With Advanced Cancer.晚期癌症医疗保险受益人的临终关怀当代模式。
JAMA Health Forum. 2025 Feb 7;6(2):e245436. doi: 10.1001/jamahealthforum.2024.5436.
10
NELBI score: a new clinical calculator of thirty-day mortality following systemic anticancer therapy in breast cancer patients near the end of life.NELBI评分：一种用于预测晚期乳腺癌患者接受全身抗癌治疗后30天死亡率的新型临床计算工具。
Breast Cancer. 2025 Mar;32(2):434-446. doi: 10.1007/s12282-025-01676-9. Epub 2025 Jan 31.